2026年4月6日 / 美国东部时间下午6:15 / 哥伦比亚广播公司（CBS）新闻
据哥伦比亚广播公司新闻独家获悉，又两家制药巨头将于周一正式在白宫旗下的折扣药品网站上销售热门商用药物。
美国制药企业艾伯维和基因泰克将成为第10家和第11家在“特朗普药房”（TrumpRx）网站上以低价提供处方药的公司。
今年1月与特朗普政府达成协议、下调部分药品价格的艾伯维，将在该网站上以86%的折扣销售修美乐（Humira）——一款用于治疗类风湿性关节炎、克罗恩病和溃疡性结肠炎的热门药物。
不过，该网站上的处方药价格仅面向未投保、或保险不覆盖该药的患者，且需患者自付全部标价。有保险的患者通常已经能享受到更低的价格。
一名白宫官员对哥伦比亚广播公司新闻表示，政府正通过“伟大医疗计划”将折扣处方药协议制度化，确保享受政府医保的人群可以使用自付额来购买特朗普药房平台的药物。国会尚未就特朗普提出的该计划进行审议。
据一名白宫官员透露，未投保患者购买修美乐笔（又称阿达木单抗）的原价超过6900美元。特朗普药房平台将提供修美乐优惠券，将价格降至950美元。
特朗普政府一直在通过“最惠国”协议降低处方药价格，即制药公司以其他国家的售价向未投保的美国消费者销售药物。
白宫去年12月宣布与基因泰克达成协议，下调流感治疗和预防单剂药片Xofluza的价格。据一名白宫官员介绍，该处方药的协商后价格约为50美元，低于原价168美元。
另一家制药公司安进也将扩大其在特朗普药房平台的产品范围，新增关节炎药物恩利（Enbrel）和斑块型银屑病治疗药物Otezla。
特朗普药房平台目前降价销售的药品已超过61种，高于今年2月该网站上线时的约40种。
https://www.cbsnews.com/video/why-experts-say-trumprx-limited/
Two more pharmaceutical companies, Abbvie and Genentech, to officially launch on TrumpRx
April 6, 2026 / 6:15 PM EDT / CBS News
Two more drug-making giants will officially start selling popular commercial medications on the White House’s discounted pharmaceutical site as soon as Monday, CBS News exclusively learned.
American pharmaceutical companies Abbvie and Genentech become the 10th and 11th companies to provide their prescriptions at a reduced rate on the “TrumpRx” site.
Abbvie, which struck a deal with the Trump administration in January to cut the cost of certain medicines, will sell Humira, a popular medication used to treat rheumatoid arthritis, Crohn’s disease and ulcerative colitis, on the site at an 86% discount.
The prescription prices on the site, however, are only available to patients who are uninsured, or whose insurance doesn’t cover it, and who must pay the full list price out of pocket. Those with insurance coverage generally pay lower prices already.
A White House official tells CBS News the administration is working to codify the discount prescription deals with the “Great Healthcare Plan” to ensure that people on government insurance can use copays for the TrumpRx drugs. Congress has not taken up the Trump-proposed plan yet.
Prices for the Humira Pen, also called adalimumab, can cost over $6,900 for uninsured individuals. TrumpRx will feature coupons for Humira that will drop the price to $950, according to a White House official.
The Trump administration has been working to lower prescription drug prices through “most-favored-nation” agreements where pharmaceutical companies sell medications to uninsured U.S. consumers at the same prices available in other countries.
The White House announced a deal with Genentech in December to reduce the cost of Xofluza, a single dose pill used to treat and prevent the flu. That prescription will cost around $50, negotiated down from $168, according to a White House official.
Another drug company, Amgen, will also expand its TrumpRx offerings to include arthritis drug Enbrel and plaque psoriasis-treating medication Otezla.
TrumpRx now sells over 61 drugs at a lower price, up from about 40 offerings when the website went live in February.
https://www.cbsnews.com/video/why-experts-say-trumprx-limited/
发表回复